| Mathematics and Statistics | 2021-2025 | 819 | CN 192 | 92.35 |
| Epidemiology | Lifetime | 276 | CN 8 | 99.66 |
| General Health Professions | Lifetime | 596 | CN 6 | 99.32 |
| Modeling and Simulation | Lifetime | 53 | CN 7 | 99.09 |
| Infectious Diseases | Lifetime | 319 | CN 12 | 98.85 |
| Pediatrics, Perinatology and Child Health | Lifetime | 490 | CN 8 | 98.57 |
| Public, Environmental and Occupational Health | Lifetime | 998 | CN 18 | 98.55 |
| Health | Lifetime | 534 | CN 9 | 96.35 |
| Finance and Banking | Lifetime | 783 | CN 25 | 95.31 |
| Health Information Management | Lifetime | 352 | CN 5 | 91.43 |
| Speech and Hearing | Lifetime | 797 | CN 16 | 79.50 |
| Infectious Diseases | 2021-2025 | 50 | CN 8 | 99.29 |
| Epidemiology | 2021-2025 | 588 | CN 61 | 94.57 |
| Modeling and Simulation | 2021-2025 | 120 | CN 26 | 94.88 |
| COVID-19 epidemiological studies | Lifetime | 9 | CN 3 | 99.85 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 44 | CN 13 | 99.75 |
| COVID-19 Clinical Research Studies | Lifetime | 57 | CN 12 | 99.61 |
| COVID-19 Pandemic Impacts | Lifetime | 7 | CN 4 | 99.44 |
| COVID-19 and Mental Health | Lifetime | 33 | CN 5 | 99.39 |
| SARS-CoV-2 detection and testing | Lifetime | 20 | CN 8 | 99.29 |
| Influenza Virus Research Studies | Lifetime | 56 | CN 8 | 99.61 |
| Respiratory viral infections research | Lifetime | 242 | CN 16 | 98.96 |
| Breastfeeding Practices and Influences | Lifetime | 104 | CN 4 | 98.68 |
| Birth, Development, and Health | Lifetime | 381 | CN 9 | 98.81 |
| Viral Infections and Outbreaks Research | Lifetime | 138 | CN 4 | 98.49 |
| Animal Disease Management and Epidemiology | Lifetime | 280 | CN 15 | 98.34 |
| Healthcare Systems and Reforms | Lifetime | 157 | CN 10 | 97.72 |
| Health Sciences Research and Education | Lifetime | 167 | CN 1 | 96.61 |
| Vaccine Coverage and Hesitancy | Lifetime | 477 | CN 14 | 96.87 |
| Data-Driven Disease Surveillance | Lifetime | 143 | CN 11 | 96.47 |
| Health disparities and outcomes | Lifetime | 853 | CN 19 | 97.10 |
| Healthcare Policy and Management | Lifetime | 753 | CN 9 | 96.71 |
| Global Health Care Issues | Lifetime | 628 | CN 29 | 95.82 |
| Smoking Behavior and Cessation | Lifetime | 572 | CN 5 | 95.86 |
| Child and Adolescent Health | Lifetime | 707 | CN 3 | 94.59 |
| Infection Control and Ventilation | Lifetime | 599 | CN 142 | 90.40 |
| Sex and Gender in Healthcare | Lifetime | 523 | CN 2 | 78.35 |
| COVID-19 Digital Contact Tracing | Lifetime | 532 | CN 27 | 52.57 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 65 | CN 8 | 99.62 |
| SARS-CoV-2 detection and testing | 2021-2025 | 18 | CN 4 | 99.09 |
| COVID-19 epidemiological studies | 2021-2025 | 40 | CN 11 | 98.93 |
| COVID-19 Clinical Research Studies | 2021-2025 | 160 | CN 19 | 99.11 |
| Respiratory viral infections research | 2021-2025 | 461 | CN 30 | 93.09 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 556 | CN 47 | 93.34 |
| Viral Infections and Outbreaks Research | 2021-2025 | 269 | CN 17 | 90.21 |
| Data-Driven Disease Surveillance | 2021-2025 | 178 | CN 21 | 83.90 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 940 | CN 42 | 54.22 |
| COVID-19 Digital Contact Tracing | 2021-2025 | 520 | CN 31 | 35.08 |